Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2025. Verfasst von Meghan B Ward und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone Marrow Transplantation and Cellular Therapy (BMTCT), St. Jude Children's Research Hospital, Memphis, TN, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Cognitive Dysfunction. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Understanding acute and long-term adverse events following CAR T cell therapy for cancer remains a crucial area of investigation as CAR T cells become more prominent in the clinic. In this issue of Cell, Geraghty and Acosta-Alvarez et al. investigate the mechanisms underlying cognitive decline in animal models following CAR T cell therapy for hematological, solid, and CNS malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bone Marrow Transplantation and Cellular Therapy (BMTCT), St. Jude Children's Research Hospital, Memphis, TN, USA.
- Department of Bone Marrow Transplantation and Cellular Therapy (BMTCT), St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: giedre.krenciute@stjude.org.
Zitieren
APA
Ward, M. B., & Krenciute, G. (2025). The neurological toll of CAR T cell therapy. Cell. https://doi.org/10.1016/j.cell.2025.04.031
Vancouver
Ward MB, Krenciute G. The neurological toll of CAR T cell therapy. Cell. 2025. doi:10.1016/j.cell.2025.04.031
BibTeX
@article{Ward2025,
author = {Ward, Meghan B and Krenciute, Giedre},
title = {The neurological toll of CAR T cell therapy},
journal = {Cell},
year = {2025},
doi = {10.1016/j.cell.2025.04.031}
}
EUVIMED